BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 22901130)

  • 21. Parametric survival analysis using R: Illustration with lung cancer data.
    Kumar M; Sonker PK; Saroj A; Jain A; Bhattacharjee A; Saroj RK
    Cancer Rep (Hoboken); 2020 Aug; 3(4):e1210. PubMed ID: 32794636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of survival analysis approaches to modelling age at first sex among youth in Kisesa Tanzania.
    Materu J; Konje ET; Urassa M; Marston M; Boerma T; Todd J
    PLoS One; 2023; 18(9):e0289942. PubMed ID: 37676876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bivariate power generalized Weibull distribution: A flexible parametric model for survival analysis.
    Jones MC; Noufaily A; Burke K
    Stat Methods Med Res; 2020 Aug; 29(8):2295-2306. PubMed ID: 31840558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models.
    Jafari-Koshki T; Mansourian M; Mokarian F
    Asian Pac J Cancer Prev; 2014; 15(22):9673-8. PubMed ID: 25520087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exponentiated Weibull regression for time-to-event data.
    Khan SA
    Lifetime Data Anal; 2018 Apr; 24(2):328-354. PubMed ID: 28349290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical comparison of survival models for analysis of cancer data.
    Moghimi-Dehkordi B; Safaee A; Pourhoseingholi MA; Fatemi R; Tabeie Z; Zali MR
    Asian Pac J Cancer Prev; 2008; 9(3):417-20. PubMed ID: 18990013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parametric survival model to identify the predictors of breast cancer mortality: An accelerated failure time approach.
    Iraji Z; Jafari Koshki T; Dolatkhah R; Asghari Jafarabadi M
    J Res Med Sci; 2020; 25():38. PubMed ID: 32582344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian and Classical Inference for the Generalized Log-Logistic Distribution with Applications to Survival Data.
    Muse AH; Mwalili S; Ngesa O; Almalki SJ; Abd-Elmougod GA
    Comput Intell Neurosci; 2021; 2021():5820435. PubMed ID: 34671390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A power series beta Weibull regression model for predicting breast carcinoma.
    Ortega EM; Cordeiro GM; Campelo AK; Kattan MW; Cancho VG
    Stat Med; 2015 Apr; 34(8):1366-88. PubMed ID: 25620602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the cure rate in Iranian breast cancer patients.
    Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis in public health research.
    Lee ET; Go OT
    Annu Rev Public Health; 1997; 18():105-34. PubMed ID: 9143714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new generalization of Weibull distribution with application to a breast cancer data set.
    Wahed AS; Luong TM; Jeong JH
    Stat Med; 2009 Jul; 28(16):2077-94. PubMed ID: 19424958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response times follow lognormal or gamma distribution in arthritis patients.
    Abrahamyan L; Beyene J; Feng J; Chon Y; Willan AR; Schmeling H; Horneff G; Keystone EC; Feldman BM
    J Clin Epidemiol; 2010 Dec; 63(12):1363-9. PubMed ID: 20430577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Is the Best Parametric Survival Models for Analyzing Hemodialysis Data?
    Vahedi M; Mahmoodi M; Mohammad K; Ossareh S; Zeraati H
    Glob J Health Sci; 2016 Oct; 8(10):56161. PubMed ID: 27302453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting.
    Wong RX; Wong FY; Lim J; Lian WX; Yap YS
    Breast; 2018 Aug; 40():38-44. PubMed ID: 29677569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.
    Abadi A; Saadat S; Yavari P; Bajdik C; Jalili P
    Asian Pac J Cancer Prev; 2011; 12(11):3113-6. PubMed ID: 22393999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling survival in hepatocellular carcinoma.
    Muszbek N; Kreif N; Valderrama A; Benedict A; Ishak J; Ross P
    Curr Med Res Opin; 2012 Jul; 28(7):1141-53. PubMed ID: 22563794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing Cox regression and parametric models for survival of patients with gastric carcinoma.
    Pourhoseingholi MA; Hajizadeh E; Moghimi Dehkordi B; Safaee A; Abadi A; Zali MR
    Asian Pac J Cancer Prev; 2007; 8(3):412-6. PubMed ID: 18159979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.